nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR7—hypertension	0.11	0.332	CbGaD
Lurasidone—ADRA2A—hypertension	0.0947	0.285	CbGaD
Lurasidone—DRD2—hypertension	0.0718	0.216	CbGaD
Lurasidone—HTR2A—hypertension	0.0555	0.167	CbGaD
Lurasidone—ADRA2C—Guanabenz—hypertension	0.0324	0.0851	CbGbCtD
Lurasidone—ADRA2C—Fenoldopam—hypertension	0.0256	0.0672	CbGbCtD
Lurasidone—HTR1A—Nebivolol—hypertension	0.0244	0.0642	CbGbCtD
Lurasidone—ADRA2A—Methyldopa—hypertension	0.0234	0.0614	CbGbCtD
Lurasidone—ADRA2A—Guanabenz—hypertension	0.0214	0.0561	CbGbCtD
Lurasidone—HTR1A—Pindolol—hypertension	0.0208	0.0545	CbGbCtD
Lurasidone—ADRA2A—Guanfacine—hypertension	0.0199	0.0522	CbGbCtD
Lurasidone—HTR1A—Penbutolol—hypertension	0.0169	0.0445	CbGbCtD
Lurasidone—ADRA2A—Fenoldopam—hypertension	0.0169	0.0444	CbGbCtD
Lurasidone—ADRA2C—Carvedilol—hypertension	0.0167	0.044	CbGbCtD
Lurasidone—ADRA2A—Doxazosin—hypertension	0.0156	0.0409	CbGbCtD
Lurasidone—DRD2—Fenoldopam—hypertension	0.0156	0.0409	CbGbCtD
Lurasidone—ADRA2C—Clonidine—hypertension	0.0147	0.0386	CbGbCtD
Lurasidone—HTR1A—Prazosin—hypertension	0.0134	0.0352	CbGbCtD
Lurasidone—ADRA2A—Prazosin—hypertension	0.0128	0.0336	CbGbCtD
Lurasidone—ADRA2A—Carvedilol—hypertension	0.011	0.029	CbGbCtD
Lurasidone—HTR1A—Propranolol—hypertension	0.0106	0.0279	CbGbCtD
Lurasidone—ADRA2A—Clonidine—hypertension	0.0097	0.0255	CbGbCtD
Lurasidone—CYP3A4—Guanethidine—hypertension	0.00652	0.0171	CbGbCtD
Lurasidone—HTR7—umbilical artery—hypertension	0.00542	0.109	CbGeAlD
Lurasidone—CYP3A4—Hydralazine—hypertension	0.00494	0.013	CbGbCtD
Lurasidone—HTR7—vas deferens—hypertension	0.00437	0.088	CbGeAlD
Lurasidone—CYP3A4—Guanfacine—hypertension	0.0042	0.011	CbGbCtD
Lurasidone—CYP3A4—Isradipine—hypertension	0.00374	0.00983	CbGbCtD
Lurasidone—HTR7—superior cervical ganglion—hypertension	0.00363	0.0733	CbGeAlD
Lurasidone—CYP3A4—Indapamide—hypertension	0.00329	0.00866	CbGbCtD
Lurasidone—CYP3A4—Nisoldipine—hypertension	0.00329	0.00866	CbGbCtD
Lurasidone—CYP3A4—Diltiazem—hypertension	0.00318	0.00836	CbGbCtD
Lurasidone—CYP3A4—Eplerenone—hypertension	0.00318	0.00836	CbGbCtD
Lurasidone—CYP3A4—Enalapril—hypertension	0.00284	0.00745	CbGbCtD
Lurasidone—CYP3A4—Irbesartan—hypertension	0.00259	0.00682	CbGbCtD
Lurasidone—CYP3A4—Amlodipine—hypertension	0.00254	0.00669	CbGbCtD
Lurasidone—HTR7—locus ceruleus—hypertension	0.00251	0.0506	CbGeAlD
Lurasidone—CYP3A4—Felodipine—hypertension	0.00245	0.00645	CbGbCtD
Lurasidone—CYP3A4—Nifedipine—hypertension	0.00237	0.00623	CbGbCtD
Lurasidone—CYP3A4—Carvedilol—hypertension	0.00234	0.00614	CbGbCtD
Lurasidone—CYP3A4—Nicardipine—hypertension	0.00234	0.00614	CbGbCtD
Lurasidone—CYP3A4—Propranolol—hypertension	0.00215	0.00565	CbGbCtD
Lurasidone—CYP3A4—Clonidine—hypertension	0.00205	0.00539	CbGbCtD
Lurasidone—HTR7—pulmonary artery—hypertension	0.00204	0.0411	CbGeAlD
Lurasidone—HTR7—sympathetic nervous system—hypertension	0.00198	0.04	CbGeAlD
Lurasidone—HTR2A—arteriole—hypertension	0.00194	0.0391	CbGeAlD
Lurasidone—HTR7—vagus nerve—hypertension	0.00192	0.0387	CbGeAlD
Lurasidone—HTR7—vein—hypertension	0.00185	0.0374	CbGeAlD
Lurasidone—CYP3A4—Atorvastatin—hypertension	0.00183	0.0048	CbGbCtD
Lurasidone—CYP3A4—Losartan—hypertension	0.00167	0.00439	CbGbCtD
Lurasidone—HTR2A—locus ceruleus—hypertension	0.00156	0.0315	CbGeAlD
Lurasidone—CYP3A4—Verapamil—hypertension	0.00148	0.00388	CbGbCtD
Lurasidone—HTR7—autonomic nervous system—hypertension	0.00133	0.0269	CbGeAlD
Lurasidone—HTR2A—pulmonary artery—hypertension	0.00127	0.0256	CbGeAlD
Lurasidone—HTR2A—sympathetic nervous system—hypertension	0.00124	0.0249	CbGeAlD
Lurasidone—HTR2A—vagus nerve—hypertension	0.0012	0.0241	CbGeAlD
Lurasidone—HTR2A—vein—hypertension	0.00116	0.0233	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—hypertension	0.000831	0.0168	CbGeAlD
Lurasidone—HTR2A—hindlimb—hypertension	0.000769	0.0155	CbGeAlD
Lurasidone—HTR7—artery—hypertension	0.000756	0.0152	CbGeAlD
Lurasidone—HTR2A—urine—hypertension	0.000677	0.0137	CbGeAlD
Lurasidone—HTR7—endothelium—hypertension	0.000638	0.0129	CbGeAlD
Lurasidone—CYP3A4—urine—hypertension	0.000627	0.0126	CbGeAlD
Lurasidone—Ziprasidone—ADRA2B—hypertension	0.000604	0.203	CrCbGaD
Lurasidone—HTR7—blood vessel—hypertension	0.000589	0.0119	CbGeAlD
Lurasidone—HTR2A—artery—hypertension	0.000471	0.0095	CbGeAlD
Lurasidone—HTR2A—endothelium—hypertension	0.000398	0.00802	CbGeAlD
Lurasidone—ADRA2C—cardiac ventricle—hypertension	0.00039	0.00785	CbGeAlD
Lurasidone—Ziprasidone—ADRA1A—hypertension	0.000374	0.126	CrCbGaD
Lurasidone—HTR2A—blood vessel—hypertension	0.000367	0.0074	CbGeAlD
Lurasidone—ADRA2C—myocardium—hypertension	0.000366	0.00739	CbGeAlD
Lurasidone—HTR1A—brainstem—hypertension	0.000337	0.00679	CbGeAlD
Lurasidone—HTR7—brainstem—hypertension	0.000322	0.00649	CbGeAlD
Lurasidone—Ziprasidone—HTR7—hypertension	0.000308	0.104	CrCbGaD
Lurasidone—DRD2—brainstem—hypertension	0.000304	0.00613	CbGeAlD
Lurasidone—Ziprasidone—HTR1B—hypertension	0.000299	0.1	CrCbGaD
Lurasidone—Ziprasidone—DRD3—hypertension	0.00029	0.0974	CrCbGaD
Lurasidone—Ziprasidone—CYP3A5—hypertension	0.000281	0.0944	CrCbGaD
Lurasidone—HTR7—heart—hypertension	0.000278	0.00561	CbGeAlD
Lurasidone—HTR7—smooth muscle tissue—hypertension	0.000276	0.00557	CbGeAlD
Lurasidone—HTR1A—cardiovascular system—hypertension	0.000275	0.00554	CbGeAlD
Lurasidone—ADRA2C—nephron tubule—hypertension	0.000269	0.00542	CbGeAlD
Lurasidone—Ziprasidone—ADRA2A—hypertension	0.000264	0.0889	CrCbGaD
Lurasidone—ADRA2C—adrenal cortex—hypertension	0.000264	0.00533	CbGeAlD
Lurasidone—HTR7—cardiovascular system—hypertension	0.000263	0.00529	CbGeAlD
Lurasidone—HTR7—kidney—hypertension	0.000257	0.00518	CbGeAlD
Lurasidone—ADRA2C—heart—hypertension	0.000256	0.00516	CbGeAlD
Lurasidone—ADRA2C—decidua—hypertension	0.000249	0.00502	CbGeAlD
Lurasidone—ADRA2C—kidney—hypertension	0.000236	0.00476	CbGeAlD
Lurasidone—ADRA2C—cortex of kidney—hypertension	0.00023	0.00464	CbGeAlD
Lurasidone—HTR7—medulla oblongata—hypertension	0.000224	0.00452	CbGeAlD
Lurasidone—ADRA2C—cardiac atrium—hypertension	0.000219	0.00441	CbGeAlD
Lurasidone—HTR1A—adrenal gland—hypertension	0.000217	0.00438	CbGeAlD
Lurasidone—HTR7—adrenal gland—hypertension	0.000208	0.00419	CbGeAlD
Lurasidone—ADRA2C—medulla oblongata—hypertension	0.000206	0.00416	CbGeAlD
Lurasidone—ADRA2A—heart—hypertension	0.000204	0.00411	CbGeAlD
Lurasidone—Ziprasidone—SLC6A4—hypertension	0.000202	0.0678	CrCbGaD
Lurasidone—Ziprasidone—DRD2—hypertension	0.000201	0.0674	CrCbGaD
Lurasidone—HTR2A—brainstem—hypertension	0.000201	0.00405	CbGeAlD
Lurasidone—ADRA2A—decidua—hypertension	0.000198	0.004	CbGeAlD
Lurasidone—ADRA2C—adrenal gland—hypertension	0.000191	0.00385	CbGeAlD
Lurasidone—HTR1A—endocrine gland—hypertension	0.000188	0.0038	CbGeAlD
Lurasidone—ADRA2A—cortex of kidney—hypertension	0.000183	0.0037	CbGeAlD
Lurasidone—HTR7—endocrine gland—hypertension	0.00018	0.00363	CbGeAlD
Lurasidone—ADRA2A—cardiac atrium—hypertension	0.000175	0.00352	CbGeAlD
Lurasidone—HTR2A—heart—hypertension	0.000174	0.0035	CbGeAlD
Lurasidone—HTR2A—smooth muscle tissue—hypertension	0.000172	0.00347	CbGeAlD
Lurasidone—DRD2—endocrine gland—hypertension	0.00017	0.00343	CbGeAlD
Lurasidone—HTR1A—central nervous system—hypertension	0.00017	0.00342	CbGeAlD
Lurasidone—ADRA2A—medulla oblongata—hypertension	0.000165	0.00332	CbGeAlD
Lurasidone—HTR2A—cardiovascular system—hypertension	0.000164	0.0033	CbGeAlD
Lurasidone—HTR7—central nervous system—hypertension	0.000162	0.00327	CbGeAlD
Lurasidone—HTR2A—kidney—hypertension	0.00016	0.00323	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—hypertension	0.000155	0.0521	CrCbGaD
Lurasidone—DRD2—central nervous system—hypertension	0.000153	0.00309	CbGeAlD
Lurasidone—ADRA2A—adrenal gland—hypertension	0.000152	0.00307	CbGeAlD
Lurasidone—ADRA2C—central nervous system—hypertension	0.000149	0.00301	CbGeAlD
Lurasidone—CYP3A4—kidney—hypertension	0.000148	0.00299	CbGeAlD
Lurasidone—HTR2A—medulla oblongata—hypertension	0.00014	0.00282	CbGeAlD
Lurasidone—ADRA2A—endocrine gland—hypertension	0.000132	0.00266	CbGeAlD
Lurasidone—HTR2A—adrenal gland—hypertension	0.00013	0.00261	CbGeAlD
Lurasidone—ADRA2A—central nervous system—hypertension	0.000119	0.0024	CbGeAlD
Lurasidone—HTR2A—endocrine gland—hypertension	0.000112	0.00226	CbGeAlD
Lurasidone—CYP3A4—endocrine gland—hypertension	0.000104	0.0021	CbGeAlD
Lurasidone—HTR2A—central nervous system—hypertension	0.000101	0.00204	CbGeAlD
Lurasidone—CYP3A4—central nervous system—hypertension	9.37e-05	0.00189	CbGeAlD
Lurasidone—Decreased appetite—Betaxolol—hypertension	2.28e-05	0.000151	CcSEcCtD
Lurasidone—Dyspnoea—Losartan—hypertension	2.28e-05	0.000151	CcSEcCtD
Lurasidone—Anxiety—Ramipril—hypertension	2.28e-05	0.000151	CcSEcCtD
Lurasidone—Somnolence—Losartan—hypertension	2.28e-05	0.000151	CcSEcCtD
Lurasidone—Dizziness—Eplerenone—hypertension	2.28e-05	0.000151	CcSEcCtD
Lurasidone—Vomiting—Indapamide—hypertension	2.28e-05	0.000151	CcSEcCtD
Lurasidone—Vomiting—Diltiazem—hypertension	2.28e-05	0.000151	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	2.28e-05	0.000151	CcSEcCtD
Lurasidone—Asthenia—Valsartan—hypertension	2.27e-05	0.00015	CcSEcCtD
Lurasidone—Hypertension—Timolol—hypertension	2.27e-05	0.00015	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Betaxolol—hypertension	2.27e-05	0.00015	CcSEcCtD
Lurasidone—Fatigue—Betaxolol—hypertension	2.27e-05	0.00015	CcSEcCtD
Lurasidone—Asthenia—Olmesartan—hypertension	2.26e-05	0.00015	CcSEcCtD
Lurasidone—Dizziness—Nifedipine—hypertension	2.26e-05	0.00015	CcSEcCtD
Lurasidone—Rash—Diltiazem—hypertension	2.26e-05	0.000149	CcSEcCtD
Lurasidone—Rash—Indapamide—hypertension	2.26e-05	0.000149	CcSEcCtD
Lurasidone—Anaemia—Lisinopril—hypertension	2.26e-05	0.000149	CcSEcCtD
Lurasidone—Dermatitis—Diltiazem—hypertension	2.25e-05	0.000149	CcSEcCtD
Lurasidone—Dermatitis—Indapamide—hypertension	2.25e-05	0.000149	CcSEcCtD
Lurasidone—Dyspepsia—Losartan—hypertension	2.25e-05	0.000149	CcSEcCtD
Lurasidone—Vomiting—Carvedilol—hypertension	2.25e-05	0.000149	CcSEcCtD
Lurasidone—Dizziness—Verapamil—hypertension	2.25e-05	0.000149	CcSEcCtD
Lurasidone—Pruritus—Valsartan—hypertension	2.24e-05	0.000148	CcSEcCtD
Lurasidone—Dry mouth—Ramipril—hypertension	2.24e-05	0.000148	CcSEcCtD
Lurasidone—Myalgia—Timolol—hypertension	2.24e-05	0.000148	CcSEcCtD
Lurasidone—Rash—Carvedilol—hypertension	2.24e-05	0.000148	CcSEcCtD
Lurasidone—Gastrointestinal pain—Perindopril—hypertension	2.23e-05	0.000148	CcSEcCtD
Lurasidone—Dermatitis—Carvedilol—hypertension	2.23e-05	0.000148	CcSEcCtD
Lurasidone—Anxiety—Timolol—hypertension	2.23e-05	0.000148	CcSEcCtD
Lurasidone—Angioedema—Lisinopril—hypertension	2.23e-05	0.000148	CcSEcCtD
Lurasidone—Pruritus—Olmesartan—hypertension	2.23e-05	0.000148	CcSEcCtD
Lurasidone—Vomiting—Doxazosin—hypertension	2.23e-05	0.000148	CcSEcCtD
Lurasidone—Decreased appetite—Losartan—hypertension	2.23e-05	0.000147	CcSEcCtD
Lurasidone—Gastrointestinal pain—Irbesartan—hypertension	2.23e-05	0.000147	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	2.22e-05	0.000147	CcSEcCtD
Lurasidone—Abdominal pain—Captopril—hypertension	2.22e-05	0.000147	CcSEcCtD
Lurasidone—Rash—Doxazosin—hypertension	2.21e-05	0.000146	CcSEcCtD
Lurasidone—Fatigue—Losartan—hypertension	2.21e-05	0.000146	CcSEcCtD
Lurasidone—Dermatitis—Doxazosin—hypertension	2.21e-05	0.000146	CcSEcCtD
Lurasidone—Gastrointestinal pain—Hydrochlorothiazide—hypertension	2.21e-05	0.000146	CcSEcCtD
Lurasidone—Vomiting—Fosinopril—hypertension	2.2e-05	0.000146	CcSEcCtD
Lurasidone—Malaise—Lisinopril—hypertension	2.2e-05	0.000146	CcSEcCtD
Lurasidone—Nausea—Propranolol—hypertension	2.2e-05	0.000145	CcSEcCtD
Lurasidone—Vertigo—Lisinopril—hypertension	2.19e-05	0.000145	CcSEcCtD
Lurasidone—Dry mouth—Timolol—hypertension	2.19e-05	0.000145	CcSEcCtD
Lurasidone—Syncope—Lisinopril—hypertension	2.19e-05	0.000145	CcSEcCtD
Lurasidone—Vomiting—Eplerenone—hypertension	2.19e-05	0.000145	CcSEcCtD
Lurasidone—Leukopenia—Lisinopril—hypertension	2.18e-05	0.000145	CcSEcCtD
Lurasidone—Rash—Fosinopril—hypertension	2.18e-05	0.000145	CcSEcCtD
Lurasidone—Dermatitis—Fosinopril—hypertension	2.18e-05	0.000144	CcSEcCtD
Lurasidone—Vomiting—Nifedipine—hypertension	2.17e-05	0.000144	CcSEcCtD
Lurasidone—Gastrointestinal pain—Furosemide—hypertension	2.17e-05	0.000144	CcSEcCtD
Lurasidone—Rash—Eplerenone—hypertension	2.17e-05	0.000144	CcSEcCtD
Lurasidone—Dermatitis—Eplerenone—hypertension	2.17e-05	0.000144	CcSEcCtD
Lurasidone—Diarrhoea—Valsartan—hypertension	2.17e-05	0.000143	CcSEcCtD
Lurasidone—Asthenia—Clonidine—hypertension	2.17e-05	0.000143	CcSEcCtD
Lurasidone—Vomiting—Verapamil—hypertension	2.16e-05	0.000143	CcSEcCtD
Lurasidone—Shock—Ramipril—hypertension	2.16e-05	0.000143	CcSEcCtD
Lurasidone—Abdominal pain—Perindopril—hypertension	2.16e-05	0.000143	CcSEcCtD
Lurasidone—Diarrhoea—Olmesartan—hypertension	2.16e-05	0.000143	CcSEcCtD
Lurasidone—Rash—Nifedipine—hypertension	2.15e-05	0.000143	CcSEcCtD
Lurasidone—Nervous system disorder—Ramipril—hypertension	2.15e-05	0.000143	CcSEcCtD
Lurasidone—Dermatitis—Nifedipine—hypertension	2.15e-05	0.000143	CcSEcCtD
Lurasidone—Abdominal pain—Irbesartan—hypertension	2.15e-05	0.000142	CcSEcCtD
Lurasidone—Loss of consciousness—Lisinopril—hypertension	2.15e-05	0.000142	CcSEcCtD
Lurasidone—Rash—Verapamil—hypertension	2.14e-05	0.000142	CcSEcCtD
Lurasidone—Tachycardia—Ramipril—hypertension	2.14e-05	0.000142	CcSEcCtD
Lurasidone—Dermatitis—Verapamil—hypertension	2.14e-05	0.000142	CcSEcCtD
Lurasidone—Pruritus—Clonidine—hypertension	2.14e-05	0.000141	CcSEcCtD
Lurasidone—Abdominal pain—Hydrochlorothiazide—hypertension	2.13e-05	0.000141	CcSEcCtD
Lurasidone—Skin disorder—Ramipril—hypertension	2.13e-05	0.000141	CcSEcCtD
Lurasidone—Infection—Timolol—hypertension	2.13e-05	0.000141	CcSEcCtD
Lurasidone—Nausea—Indapamide—hypertension	2.13e-05	0.000141	CcSEcCtD
Lurasidone—Nausea—Diltiazem—hypertension	2.13e-05	0.000141	CcSEcCtD
Lurasidone—Hyperhidrosis—Ramipril—hypertension	2.12e-05	0.000141	CcSEcCtD
Lurasidone—Asthenia—Trandolapril—hypertension	2.11e-05	0.00014	CcSEcCtD
Lurasidone—Shock—Timolol—hypertension	2.11e-05	0.00014	CcSEcCtD
Lurasidone—Nervous system disorder—Timolol—hypertension	2.11e-05	0.000139	CcSEcCtD
Lurasidone—Nausea—Carvedilol—hypertension	2.11e-05	0.000139	CcSEcCtD
Lurasidone—Asthenia—Enalapril—hypertension	2.1e-05	0.000139	CcSEcCtD
Lurasidone—Abdominal pain—Furosemide—hypertension	2.1e-05	0.000139	CcSEcCtD
Lurasidone—Gastrointestinal pain—Losartan—hypertension	2.09e-05	0.000139	CcSEcCtD
Lurasidone—Dizziness—Valsartan—hypertension	2.09e-05	0.000139	CcSEcCtD
Lurasidone—Skin disorder—Timolol—hypertension	2.09e-05	0.000138	CcSEcCtD
Lurasidone—Dizziness—Olmesartan—hypertension	2.08e-05	0.000138	CcSEcCtD
Lurasidone—Pruritus—Trandolapril—hypertension	2.08e-05	0.000138	CcSEcCtD
Lurasidone—Nausea—Doxazosin—hypertension	2.08e-05	0.000138	CcSEcCtD
Lurasidone—Myalgia—Lisinopril—hypertension	2.08e-05	0.000138	CcSEcCtD
Lurasidone—Hyperhidrosis—Timolol—hypertension	2.08e-05	0.000137	CcSEcCtD
Lurasidone—Asthenia—Telmisartan—hypertension	2.08e-05	0.000137	CcSEcCtD
Lurasidone—Pruritus—Enalapril—hypertension	2.07e-05	0.000137	CcSEcCtD
Lurasidone—Anxiety—Lisinopril—hypertension	2.07e-05	0.000137	CcSEcCtD
Lurasidone—Diarrhoea—Clonidine—hypertension	2.07e-05	0.000137	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	2.06e-05	0.000137	CcSEcCtD
Lurasidone—Nausea—Fosinopril—hypertension	2.06e-05	0.000136	CcSEcCtD
Lurasidone—Hypotension—Ramipril—hypertension	2.05e-05	0.000136	CcSEcCtD
Lurasidone—Pruritus—Telmisartan—hypertension	2.05e-05	0.000135	CcSEcCtD
Lurasidone—Nausea—Eplerenone—hypertension	2.04e-05	0.000135	CcSEcCtD
Lurasidone—Dry mouth—Lisinopril—hypertension	2.03e-05	0.000135	CcSEcCtD
Lurasidone—Nausea—Nifedipine—hypertension	2.03e-05	0.000134	CcSEcCtD
Lurasidone—Abdominal pain—Losartan—hypertension	2.02e-05	0.000134	CcSEcCtD
Lurasidone—Nausea—Verapamil—hypertension	2.02e-05	0.000134	CcSEcCtD
Lurasidone—Asthenia—Captopril—hypertension	2.02e-05	0.000134	CcSEcCtD
Lurasidone—Diarrhoea—Trandolapril—hypertension	2.01e-05	0.000133	CcSEcCtD
Lurasidone—Vomiting—Valsartan—hypertension	2.01e-05	0.000133	CcSEcCtD
Lurasidone—Diarrhoea—Enalapril—hypertension	2.01e-05	0.000133	CcSEcCtD
Lurasidone—Hypotension—Timolol—hypertension	2.01e-05	0.000133	CcSEcCtD
Lurasidone—Vomiting—Olmesartan—hypertension	2e-05	0.000133	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Ramipril—hypertension	2e-05	0.000132	CcSEcCtD
Lurasidone—Rash—Valsartan—hypertension	2e-05	0.000132	CcSEcCtD
Lurasidone—Dizziness—Clonidine—hypertension	2e-05	0.000132	CcSEcCtD
Lurasidone—Dermatitis—Valsartan—hypertension	2e-05	0.000132	CcSEcCtD
Lurasidone—Pruritus—Captopril—hypertension	1.99e-05	0.000132	CcSEcCtD
Lurasidone—Rash—Olmesartan—hypertension	1.99e-05	0.000132	CcSEcCtD
Lurasidone—Insomnia—Ramipril—hypertension	1.99e-05	0.000132	CcSEcCtD
Lurasidone—Dermatitis—Olmesartan—hypertension	1.99e-05	0.000131	CcSEcCtD
Lurasidone—Diarrhoea—Telmisartan—hypertension	1.98e-05	0.000131	CcSEcCtD
Lurasidone—Infection—Lisinopril—hypertension	1.98e-05	0.000131	CcSEcCtD
Lurasidone—Shock—Lisinopril—hypertension	1.96e-05	0.00013	CcSEcCtD
Lurasidone—Asthenia—Perindopril—hypertension	1.96e-05	0.00013	CcSEcCtD
Lurasidone—Dyspnoea—Ramipril—hypertension	1.96e-05	0.00013	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Timolol—hypertension	1.96e-05	0.00013	CcSEcCtD
Lurasidone—Asthenia—Irbesartan—hypertension	1.95e-05	0.000129	CcSEcCtD
Lurasidone—Somnolence—Ramipril—hypertension	1.95e-05	0.000129	CcSEcCtD
Lurasidone—Dizziness—Trandolapril—hypertension	1.95e-05	0.000129	CcSEcCtD
Lurasidone—Tachycardia—Lisinopril—hypertension	1.94e-05	0.000129	CcSEcCtD
Lurasidone—Insomnia—Timolol—hypertension	1.94e-05	0.000129	CcSEcCtD
Lurasidone—Dizziness—Enalapril—hypertension	1.94e-05	0.000128	CcSEcCtD
Lurasidone—Asthenia—Hydrochlorothiazide—hypertension	1.94e-05	0.000128	CcSEcCtD
Lurasidone—Skin disorder—Lisinopril—hypertension	1.93e-05	0.000128	CcSEcCtD
Lurasidone—Dyspepsia—Ramipril—hypertension	1.93e-05	0.000128	CcSEcCtD
Lurasidone—Pruritus—Perindopril—hypertension	1.93e-05	0.000128	CcSEcCtD
Lurasidone—Pruritus—Irbesartan—hypertension	1.93e-05	0.000127	CcSEcCtD
Lurasidone—Hyperhidrosis—Lisinopril—hypertension	1.93e-05	0.000127	CcSEcCtD
Lurasidone—Diarrhoea—Captopril—hypertension	1.92e-05	0.000127	CcSEcCtD
Lurasidone—Vomiting—Clonidine—hypertension	1.92e-05	0.000127	CcSEcCtD
Lurasidone—Dyspnoea—Timolol—hypertension	1.91e-05	0.000127	CcSEcCtD
Lurasidone—Dizziness—Telmisartan—hypertension	1.91e-05	0.000127	CcSEcCtD
Lurasidone—Pruritus—Hydrochlorothiazide—hypertension	1.91e-05	0.000126	CcSEcCtD
Lurasidone—Decreased appetite—Ramipril—hypertension	1.91e-05	0.000126	CcSEcCtD
Lurasidone—Somnolence—Timolol—hypertension	1.91e-05	0.000126	CcSEcCtD
Lurasidone—Asthenia—Furosemide—hypertension	1.9e-05	0.000126	CcSEcCtD
Lurasidone—Rash—Clonidine—hypertension	1.9e-05	0.000126	CcSEcCtD
Lurasidone—Dermatitis—Clonidine—hypertension	1.9e-05	0.000126	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Ramipril—hypertension	1.9e-05	0.000126	CcSEcCtD
Lurasidone—Fatigue—Ramipril—hypertension	1.89e-05	0.000125	CcSEcCtD
Lurasidone—Dyspepsia—Timolol—hypertension	1.89e-05	0.000125	CcSEcCtD
Lurasidone—Asthenia—Betaxolol—hypertension	1.89e-05	0.000125	CcSEcCtD
Lurasidone—Nausea—Valsartan—hypertension	1.88e-05	0.000125	CcSEcCtD
Lurasidone—Pruritus—Furosemide—hypertension	1.88e-05	0.000124	CcSEcCtD
Lurasidone—Nausea—Olmesartan—hypertension	1.87e-05	0.000124	CcSEcCtD
Lurasidone—Vomiting—Trandolapril—hypertension	1.87e-05	0.000124	CcSEcCtD
Lurasidone—Diarrhoea—Perindopril—hypertension	1.87e-05	0.000124	CcSEcCtD
Lurasidone—Decreased appetite—Timolol—hypertension	1.87e-05	0.000124	CcSEcCtD
Lurasidone—Vomiting—Enalapril—hypertension	1.86e-05	0.000123	CcSEcCtD
Lurasidone—Diarrhoea—Irbesartan—hypertension	1.86e-05	0.000123	CcSEcCtD
Lurasidone—Hypotension—Lisinopril—hypertension	1.86e-05	0.000123	CcSEcCtD
Lurasidone—Dizziness—Captopril—hypertension	1.86e-05	0.000123	CcSEcCtD
Lurasidone—Pruritus—Betaxolol—hypertension	1.86e-05	0.000123	CcSEcCtD
Lurasidone—Rash—Trandolapril—hypertension	1.86e-05	0.000123	CcSEcCtD
Lurasidone—Dermatitis—Trandolapril—hypertension	1.85e-05	0.000123	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Timolol—hypertension	1.85e-05	0.000123	CcSEcCtD
Lurasidone—Fatigue—Timolol—hypertension	1.85e-05	0.000123	CcSEcCtD
Lurasidone—Rash—Enalapril—hypertension	1.85e-05	0.000122	CcSEcCtD
Lurasidone—Dermatitis—Enalapril—hypertension	1.85e-05	0.000122	CcSEcCtD
Lurasidone—Diarrhoea—Hydrochlorothiazide—hypertension	1.85e-05	0.000122	CcSEcCtD
Lurasidone—Vomiting—Telmisartan—hypertension	1.84e-05	0.000122	CcSEcCtD
Lurasidone—Asthenia—Losartan—hypertension	1.84e-05	0.000122	CcSEcCtD
Lurasidone—Rash—Telmisartan—hypertension	1.82e-05	0.000121	CcSEcCtD
Lurasidone—Dermatitis—Telmisartan—hypertension	1.82e-05	0.000121	CcSEcCtD
Lurasidone—Diarrhoea—Furosemide—hypertension	1.82e-05	0.00012	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Lisinopril—hypertension	1.81e-05	0.00012	CcSEcCtD
Lurasidone—Pruritus—Losartan—hypertension	1.81e-05	0.00012	CcSEcCtD
Lurasidone—Dizziness—Perindopril—hypertension	1.81e-05	0.00012	CcSEcCtD
Lurasidone—Insomnia—Lisinopril—hypertension	1.8e-05	0.000119	CcSEcCtD
Lurasidone—Dizziness—Irbesartan—hypertension	1.8e-05	0.000119	CcSEcCtD
Lurasidone—Diarrhoea—Betaxolol—hypertension	1.8e-05	0.000119	CcSEcCtD
Lurasidone—Gastrointestinal pain—Ramipril—hypertension	1.8e-05	0.000119	CcSEcCtD
Lurasidone—Nausea—Clonidine—hypertension	1.79e-05	0.000119	CcSEcCtD
Lurasidone—Vomiting—Captopril—hypertension	1.79e-05	0.000118	CcSEcCtD
Lurasidone—Dizziness—Hydrochlorothiazide—hypertension	1.79e-05	0.000118	CcSEcCtD
Lurasidone—Dyspnoea—Lisinopril—hypertension	1.78e-05	0.000118	CcSEcCtD
Lurasidone—Rash—Captopril—hypertension	1.77e-05	0.000117	CcSEcCtD
Lurasidone—Dermatitis—Captopril—hypertension	1.77e-05	0.000117	CcSEcCtD
Lurasidone—Somnolence—Lisinopril—hypertension	1.77e-05	0.000117	CcSEcCtD
Lurasidone—Gastrointestinal pain—Timolol—hypertension	1.76e-05	0.000116	CcSEcCtD
Lurasidone—Dizziness—Furosemide—hypertension	1.76e-05	0.000116	CcSEcCtD
Lurasidone—Dyspepsia—Lisinopril—hypertension	1.75e-05	0.000116	CcSEcCtD
Lurasidone—Diarrhoea—Losartan—hypertension	1.75e-05	0.000116	CcSEcCtD
Lurasidone—Nausea—Trandolapril—hypertension	1.75e-05	0.000116	CcSEcCtD
Lurasidone—Nausea—Enalapril—hypertension	1.74e-05	0.000115	CcSEcCtD
Lurasidone—Dizziness—Betaxolol—hypertension	1.74e-05	0.000115	CcSEcCtD
Lurasidone—Vomiting—Perindopril—hypertension	1.74e-05	0.000115	CcSEcCtD
Lurasidone—Abdominal pain—Ramipril—hypertension	1.74e-05	0.000115	CcSEcCtD
Lurasidone—Decreased appetite—Lisinopril—hypertension	1.73e-05	0.000115	CcSEcCtD
Lurasidone—Vomiting—Irbesartan—hypertension	1.73e-05	0.000115	CcSEcCtD
Lurasidone—Rash—Perindopril—hypertension	1.72e-05	0.000114	CcSEcCtD
Lurasidone—Dermatitis—Perindopril—hypertension	1.72e-05	0.000114	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Lisinopril—hypertension	1.72e-05	0.000114	CcSEcCtD
Lurasidone—Nausea—Telmisartan—hypertension	1.72e-05	0.000114	CcSEcCtD
Lurasidone—Fatigue—Lisinopril—hypertension	1.72e-05	0.000114	CcSEcCtD
Lurasidone—Vomiting—Hydrochlorothiazide—hypertension	1.72e-05	0.000114	CcSEcCtD
Lurasidone—Rash—Irbesartan—hypertension	1.72e-05	0.000114	CcSEcCtD
Lurasidone—Dermatitis—Irbesartan—hypertension	1.71e-05	0.000114	CcSEcCtD
Lurasidone—Rash—Hydrochlorothiazide—hypertension	1.7e-05	0.000113	CcSEcCtD
Lurasidone—Dermatitis—Hydrochlorothiazide—hypertension	1.7e-05	0.000113	CcSEcCtD
Lurasidone—Abdominal pain—Timolol—hypertension	1.7e-05	0.000112	CcSEcCtD
Lurasidone—Dizziness—Losartan—hypertension	1.69e-05	0.000112	CcSEcCtD
Lurasidone—Vomiting—Furosemide—hypertension	1.69e-05	0.000112	CcSEcCtD
Lurasidone—Rash—Furosemide—hypertension	1.67e-05	0.000111	CcSEcCtD
Lurasidone—Dermatitis—Furosemide—hypertension	1.67e-05	0.000111	CcSEcCtD
Lurasidone—Vomiting—Betaxolol—hypertension	1.67e-05	0.000111	CcSEcCtD
Lurasidone—Nausea—Captopril—hypertension	1.67e-05	0.000111	CcSEcCtD
Lurasidone—Rash—Betaxolol—hypertension	1.66e-05	0.00011	CcSEcCtD
Lurasidone—Dermatitis—Betaxolol—hypertension	1.66e-05	0.00011	CcSEcCtD
Lurasidone—Gastrointestinal pain—Lisinopril—hypertension	1.63e-05	0.000108	CcSEcCtD
Lurasidone—Vomiting—Losartan—hypertension	1.63e-05	0.000108	CcSEcCtD
Lurasidone—Nausea—Perindopril—hypertension	1.62e-05	0.000107	CcSEcCtD
Lurasidone—Nausea—Irbesartan—hypertension	1.62e-05	0.000107	CcSEcCtD
Lurasidone—Rash—Losartan—hypertension	1.62e-05	0.000107	CcSEcCtD
Lurasidone—Dermatitis—Losartan—hypertension	1.61e-05	0.000107	CcSEcCtD
Lurasidone—Nausea—Hydrochlorothiazide—hypertension	1.6e-05	0.000106	CcSEcCtD
Lurasidone—Nausea—Furosemide—hypertension	1.58e-05	0.000104	CcSEcCtD
Lurasidone—Asthenia—Ramipril—hypertension	1.58e-05	0.000104	CcSEcCtD
Lurasidone—Abdominal pain—Lisinopril—hypertension	1.57e-05	0.000104	CcSEcCtD
Lurasidone—Nausea—Betaxolol—hypertension	1.56e-05	0.000103	CcSEcCtD
Lurasidone—Pruritus—Ramipril—hypertension	1.55e-05	0.000103	CcSEcCtD
Lurasidone—Asthenia—Timolol—hypertension	1.54e-05	0.000102	CcSEcCtD
Lurasidone—Nausea—Losartan—hypertension	1.52e-05	0.000101	CcSEcCtD
Lurasidone—Pruritus—Timolol—hypertension	1.52e-05	0.000101	CcSEcCtD
Lurasidone—Diarrhoea—Ramipril—hypertension	1.5e-05	9.95e-05	CcSEcCtD
Lurasidone—Diarrhoea—Timolol—hypertension	1.47e-05	9.73e-05	CcSEcCtD
Lurasidone—Dizziness—Ramipril—hypertension	1.45e-05	9.62e-05	CcSEcCtD
Lurasidone—Asthenia—Lisinopril—hypertension	1.43e-05	9.46e-05	CcSEcCtD
Lurasidone—Dizziness—Timolol—hypertension	1.42e-05	9.4e-05	CcSEcCtD
Lurasidone—Pruritus—Lisinopril—hypertension	1.41e-05	9.33e-05	CcSEcCtD
Lurasidone—Vomiting—Ramipril—hypertension	1.4e-05	9.25e-05	CcSEcCtD
Lurasidone—Rash—Ramipril—hypertension	1.38e-05	9.17e-05	CcSEcCtD
Lurasidone—Dermatitis—Ramipril—hypertension	1.38e-05	9.16e-05	CcSEcCtD
Lurasidone—Vomiting—Timolol—hypertension	1.37e-05	9.04e-05	CcSEcCtD
Lurasidone—Diarrhoea—Lisinopril—hypertension	1.36e-05	9.02e-05	CcSEcCtD
Lurasidone—Rash—Timolol—hypertension	1.35e-05	8.96e-05	CcSEcCtD
Lurasidone—Dermatitis—Timolol—hypertension	1.35e-05	8.96e-05	CcSEcCtD
Lurasidone—Dizziness—Lisinopril—hypertension	1.32e-05	8.72e-05	CcSEcCtD
Lurasidone—Nausea—Ramipril—hypertension	1.3e-05	8.64e-05	CcSEcCtD
Lurasidone—Nausea—Timolol—hypertension	1.28e-05	8.44e-05	CcSEcCtD
Lurasidone—Vomiting—Lisinopril—hypertension	1.27e-05	8.39e-05	CcSEcCtD
Lurasidone—Rash—Lisinopril—hypertension	1.26e-05	8.32e-05	CcSEcCtD
Lurasidone—Dermatitis—Lisinopril—hypertension	1.25e-05	8.31e-05	CcSEcCtD
Lurasidone—Nausea—Lisinopril—hypertension	1.18e-05	7.83e-05	CcSEcCtD
Lurasidone—ADRA2C—Signaling Pathways—POMC—hypertension	1.81e-06	2.17e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—F2—hypertension	1.8e-06	2.16e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PRKCB—hypertension	1.8e-06	2.16e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FN1—hypertension	1.8e-06	2.16e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—INS—hypertension	1.8e-06	2.15e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF1—hypertension	1.8e-06	2.15e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT2—hypertension	1.8e-06	2.15e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—EGFR—hypertension	1.79e-06	2.14e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PDGFB—hypertension	1.79e-06	2.14e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PPARG—hypertension	1.78e-06	2.13e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FGFR1—hypertension	1.78e-06	2.13e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FN1—hypertension	1.77e-06	2.12e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PRKCB—hypertension	1.77e-06	2.12e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—F2—hypertension	1.77e-06	2.12e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL2—hypertension	1.77e-06	2.12e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MMP9—hypertension	1.76e-06	2.11e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NOTCH1—hypertension	1.76e-06	2.11e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CDKN1A—hypertension	1.76e-06	2.11e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—POMC—hypertension	1.76e-06	2.1e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PTEN—hypertension	1.75e-06	2.1e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HIF1A—hypertension	1.75e-06	2.1e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALDH2—hypertension	1.75e-06	2.09e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—INS—hypertension	1.75e-06	2.09e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AGT—hypertension	1.74e-06	2.09e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF1—hypertension	1.74e-06	2.08e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT2—hypertension	1.74e-06	2.08e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—AKT1—hypertension	1.74e-06	2.08e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NOTCH1—hypertension	1.73e-06	2.08e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—EGFR—hypertension	1.73e-06	2.07e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTGS2—hypertension	1.72e-06	2.07e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MAPK8—hypertension	1.72e-06	2.06e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CALM1—hypertension	1.72e-06	2.05e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AKT1—hypertension	1.71e-06	2.05e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—LEP—hypertension	1.71e-06	2.05e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOE—hypertension	1.71e-06	2.05e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SERPINE1—hypertension	1.71e-06	2.04e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HBA1—hypertension	1.7e-06	2.04e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CAV1—hypertension	1.69e-06	2.03e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP11A1—hypertension	1.69e-06	2.03e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOA1—hypertension	1.69e-06	2.02e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—KDR—hypertension	1.67e-06	2.01e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—EP300—hypertension	1.67e-06	2e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTT1—hypertension	1.66e-06	1.99e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC9A1—hypertension	1.66e-06	1.99e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FGF2—hypertension	1.65e-06	1.98e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SERPINE1—hypertension	1.65e-06	1.98e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RHOA—hypertension	1.65e-06	1.97e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCLC—hypertension	1.64e-06	1.97e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CETP—hypertension	1.64e-06	1.97e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—POMC—hypertension	1.64e-06	1.97e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—INS—hypertension	1.63e-06	1.95e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PIK3R1—hypertension	1.63e-06	1.95e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NOS3—hypertension	1.63e-06	1.95e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—SRC—hypertension	1.63e-06	1.95e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—POMC—hypertension	1.61e-06	1.93e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—F2—hypertension	1.61e-06	1.93e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PRKCB—hypertension	1.61e-06	1.93e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FN1—hypertension	1.61e-06	1.93e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—INS—hypertension	1.61e-06	1.92e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL2—hypertension	1.61e-06	1.92e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ALB—hypertension	1.6e-06	1.92e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FGF2—hypertension	1.6e-06	1.92e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RHOA—hypertension	1.59e-06	1.91e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—VEGFA—hypertension	1.58e-06	1.9e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL2—hypertension	1.58e-06	1.89e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF1—hypertension	1.58e-06	1.89e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NOTCH1—hypertension	1.58e-06	1.89e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT2—hypertension	1.58e-06	1.89e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PIK3R1—hypertension	1.58e-06	1.89e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NOS3—hypertension	1.58e-06	1.89e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP17A1—hypertension	1.57e-06	1.88e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—EGFR—hypertension	1.57e-06	1.88e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS1—hypertension	1.56e-06	1.87e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ENO1—hypertension	1.56e-06	1.87e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF1—hypertension	1.55e-06	1.86e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT2—hypertension	1.55e-06	1.86e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—EGFR—hypertension	1.55e-06	1.85e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RELA—hypertension	1.53e-06	1.84e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3R1—hypertension	1.53e-06	1.83e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—NOS3—hypertension	1.53e-06	1.83e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MTOR—hypertension	1.5e-06	1.8e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTEN—hypertension	1.5e-06	1.8e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CTGF—hypertension	1.5e-06	1.8e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SERPINE1—hypertension	1.5e-06	1.79e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMGCR—hypertension	1.49e-06	1.78e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GOT2—hypertension	1.49e-06	1.78e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RELA—hypertension	1.48e-06	1.78e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SERPINE1—hypertension	1.47e-06	1.77e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—POMC—hypertension	1.47e-06	1.76e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—INS—hypertension	1.46e-06	1.75e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MYC—hypertension	1.46e-06	1.75e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MTOR—hypertension	1.46e-06	1.74e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TGFB1—hypertension	1.45e-06	1.74e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADRA2A—hypertension	1.45e-06	1.74e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FGF2—hypertension	1.45e-06	1.74e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RHOA—hypertension	1.45e-06	1.73e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CXCL8—hypertension	1.45e-06	1.73e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL2—hypertension	1.44e-06	1.72e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—EP300—hypertension	1.43e-06	1.72e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NOS3—hypertension	1.43e-06	1.71e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PIK3R1—hypertension	1.43e-06	1.71e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FGF2—hypertension	1.43e-06	1.71e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—EGFR—hypertension	1.43e-06	1.71e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RHOA—hypertension	1.42e-06	1.7e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1—hypertension	1.41e-06	1.69e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT2—hypertension	1.41e-06	1.69e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PIK3R1—hypertension	1.41e-06	1.69e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NOS3—hypertension	1.41e-06	1.69e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—EGFR—hypertension	1.41e-06	1.68e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTGS2—hypertension	1.4e-06	1.68e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CXCL8—hypertension	1.4e-06	1.68e-05	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AKT1—hypertension	1.4e-06	1.67e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—hypertension	1.37e-06	1.65e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TH—hypertension	1.36e-06	1.63e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CALM2—hypertension	1.36e-06	1.62e-05	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AKT1—hypertension	1.35e-06	1.62e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RELA—hypertension	1.35e-06	1.61e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SERPINE1—hypertension	1.34e-06	1.61e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—hypertension	1.33e-06	1.59e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RELA—hypertension	1.33e-06	1.59e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC2A4—hypertension	1.32e-06	1.59e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCG—hypertension	1.32e-06	1.59e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MTOR—hypertension	1.32e-06	1.58e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MMP9—hypertension	1.31e-06	1.57e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CDKN1A—hypertension	1.3e-06	1.56e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PTEN—hypertension	1.3e-06	1.56e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MTOR—hypertension	1.3e-06	1.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FGF2—hypertension	1.3e-06	1.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RHOA—hypertension	1.29e-06	1.55e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GOT1—hypertension	1.28e-06	1.54e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NOS3—hypertension	1.28e-06	1.53e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PIK3R1—hypertension	1.28e-06	1.53e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MAPK8—hypertension	1.27e-06	1.52e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CXCL8—hypertension	1.27e-06	1.52e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AKT1—hypertension	1.27e-06	1.52e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MMP9—hypertension	1.27e-06	1.52e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CDKN1A—hypertension	1.26e-06	1.51e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PTEN—hypertension	1.26e-06	1.51e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CXCL8—hypertension	1.25e-06	1.5e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—STK11—hypertension	1.25e-06	1.49e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP19A1—hypertension	1.25e-06	1.49e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—EP300—hypertension	1.24e-06	1.48e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MAPK8—hypertension	1.23e-06	1.47e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AKT1—hypertension	1.23e-06	1.47e-05	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AKT1—hypertension	1.23e-06	1.47e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTEN—hypertension	1.22e-06	1.46e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—hypertension	1.21e-06	1.45e-05	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AKT1—hypertension	1.21e-06	1.44e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RELA—hypertension	1.21e-06	1.44e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SRC—hypertension	1.21e-06	1.44e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—EP300—hypertension	1.2e-06	1.44e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TP53—hypertension	1.2e-06	1.43e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—hypertension	1.19e-06	1.42e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MTOR—hypertension	1.18e-06	1.42e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—VEGFA—hypertension	1.17e-06	1.41e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SRC—hypertension	1.17e-06	1.4e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—EP300—hypertension	1.17e-06	1.4e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—COMT—hypertension	1.16e-06	1.39e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MMP9—hypertension	1.15e-06	1.37e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CDKN1A—hypertension	1.14e-06	1.37e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GNB3—hypertension	1.14e-06	1.37e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARGC1A—hypertension	1.14e-06	1.37e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PTEN—hypertension	1.14e-06	1.37e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMOX1—hypertension	1.14e-06	1.36e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCL8—hypertension	1.14e-06	1.36e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—VEGFA—hypertension	1.14e-06	1.36e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MMP9—hypertension	1.13e-06	1.35e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CDKN1A—hypertension	1.13e-06	1.35e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PTEN—hypertension	1.12e-06	1.34e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CAT—hypertension	1.12e-06	1.34e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MAPK8—hypertension	1.12e-06	1.34e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AKT1—hypertension	1.11e-06	1.33e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GNAS—hypertension	1.11e-06	1.33e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MAPK8—hypertension	1.1e-06	1.32e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AKT1—hypertension	1.1e-06	1.31e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—hypertension	1.1e-06	1.31e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AKT1—hypertension	1.1e-06	1.31e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—EP300—hypertension	1.09e-06	1.3e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOB—hypertension	1.09e-06	1.3e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—hypertension	1.08e-06	1.29e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MYC—hypertension	1.08e-06	1.29e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TGFB1—hypertension	1.08e-06	1.29e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—EP300—hypertension	1.07e-06	1.28e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTM1—hypertension	1.06e-06	1.27e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SRC—hypertension	1.06e-06	1.27e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—EGFR—hypertension	1.06e-06	1.27e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MYC—hypertension	1.05e-06	1.25e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TGFB1—hypertension	1.04e-06	1.25e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SRC—hypertension	1.04e-06	1.25e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LPL—hypertension	1.04e-06	1.24e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—VEGFA—hypertension	1.03e-06	1.23e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MMP9—hypertension	1.03e-06	1.23e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CDKN1A—hypertension	1.02e-06	1.23e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—EGFR—hypertension	1.02e-06	1.22e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PTEN—hypertension	1.02e-06	1.22e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADCY5—hypertension	1.02e-06	1.22e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—VEGFA—hypertension	1.01e-06	1.21e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX1—hypertension	1.01e-06	1.21e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AKT1—hypertension	1.01e-06	1.21e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PRKCA—hypertension	1e-06	1.2e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP1A1—hypertension	1e-06	1.2e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MAPK8—hypertension	9.99e-07	1.2e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AKT1—hypertension	9.97e-07	1.19e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CD36—hypertension	9.87e-07	1.18e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—EP300—hypertension	9.74e-07	1.17e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MYC—hypertension	9.48e-07	1.14e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SRC—hypertension	9.47e-07	1.13e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TGFB1—hypertension	9.46e-07	1.13e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—hypertension	9.36e-07	1.12e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MYC—hypertension	9.33e-07	1.12e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TGFB1—hypertension	9.31e-07	1.11e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—EGFR—hypertension	9.28e-07	1.11e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—VEGFA—hypertension	9.23e-07	1.11e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARA—hypertension	9.18e-07	1.1e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—EGFR—hypertension	9.13e-07	1.09e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AGT—hypertension	8.89e-07	1.06e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TP53—hypertension	8.87e-07	1.06e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CALM1—hypertension	8.74e-07	1.05e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOE—hypertension	8.71e-07	1.04e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—AKT1—hypertension	8.67e-07	1.04e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CAV1—hypertension	8.63e-07	1.03e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOA1—hypertension	8.61e-07	1.03e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TP53—hypertension	8.58e-07	1.03e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MYC—hypertension	8.49e-07	1.02e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TGFB1—hypertension	8.47e-07	1.01e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—EGFR—hypertension	8.3e-07	9.95e-06	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—hypertension	8.12e-07	9.73e-06	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—hypertension	7.86e-07	9.41e-06	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TP53—hypertension	7.79e-07	9.33e-06	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TP53—hypertension	7.66e-07	9.18e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARG—hypertension	7.59e-07	9.09e-06	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT1—hypertension	7.49e-07	8.97e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—POMC—hypertension	7.48e-07	8.96e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—INS—hypertension	7.44e-07	8.91e-06	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT1—hypertension	7.25e-07	8.68e-06	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—hypertension	7.13e-07	8.54e-06	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AKT1—hypertension	7.04e-07	8.43e-06	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—hypertension	7.01e-07	8.4e-06	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TP53—hypertension	6.97e-07	8.35e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALB—hypertension	6.82e-07	8.17e-06	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT1—hypertension	6.58e-07	7.88e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NOS3—hypertension	6.53e-07	7.82e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3R1—hypertension	6.53e-07	7.82e-06	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT1—hypertension	6.47e-07	7.75e-06	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—hypertension	6.38e-07	7.64e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS2—hypertension	5.97e-07	7.15e-06	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT1—hypertension	5.89e-07	7.05e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTEN—hypertension	5.21e-07	6.23e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—EP300—hypertension	4.96e-07	5.95e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AKT1—hypertension	3e-07	3.59e-06	CbGpPWpGaD
